Acadian Asset Management LLC Sells 468,602 Shares of Indivior PLC (NASDAQ:INDV)

Acadian Asset Management LLC decreased its position in Indivior PLC (NASDAQ:INDV) by 28.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,175,457 shares of the company’s stock after selling 468,602 shares during the quarter. Acadian Asset Management LLC’s holdings in Indivior were worth $25,141,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Campbell & CO Investment Adviser LLC grew its position in shares of Indivior by 2.8% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 37,948 shares of the company’s stock worth $573,000 after purchasing an additional 1,037 shares in the last quarter. Renaissance Group LLC lifted its stake in shares of Indivior by 6.1% during the 4th quarter. Renaissance Group LLC now owns 103,023 shares of the company’s stock worth $1,573,000 after acquiring an additional 5,896 shares during the last quarter. Chilton Investment Co. Inc. bought a new stake in shares of Indivior during the 4th quarter worth approximately $263,000. ADAR1 Capital Management LLC bought a new stake in Indivior during the 4th quarter valued at $368,000. Finally, Royal London Asset Management Ltd. raised its position in Indivior by 5.8% during the 4th quarter. Royal London Asset Management Ltd. now owns 447,828 shares of the company’s stock valued at $6,838,000 after purchasing an additional 24,383 shares in the last quarter. Institutional investors own 60.33% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum decreased their target price on Indivior from $37.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th.

Indivior Stock Up 0.1 %

NASDAQ INDV traded up $0.01 on Monday, reaching $10.42. 182,004 shares of the stock traded hands, compared to its average volume of 202,343. The company has a debt-to-equity ratio of 23.50, a quick ratio of 0.74 and a current ratio of 0.92. The company has a fifty day moving average price of $15.67 and a 200-day moving average price of $17.80. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 1,041.00 and a beta of 0.69. Indivior PLC has a 12 month low of $9.14 and a 12 month high of $24.77.

Indivior (NASDAQ:INDV) last announced its quarterly earnings results on Thursday, April 25th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Indivior had a net margin of 0.44% and a return on equity of 842.72%. The company had revenue of $284.00 million during the quarter, compared to analysts’ expectations of $300.00 million. As a group, research analysts forecast that Indivior PLC will post 1.8 EPS for the current fiscal year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.